[Ip-health] LDC pharmaceutical extension request fully warranted

Baker, Brook b.baker at neu.edu
Wed Feb 25 20:20:19 PST 2015


Intro
LDCs Members have submitted a duly motivated request for an unconditional extension of the 2002-2016 pharmaceutical transition period (covering patents and data) and for relief from the requirements of TRIPS Article 70.8 and 70.9 (mailbox and marketing exclusivity provisions).  This expert analysis confirm LDCs' need and entitlement to the requested extension.??
http://infojustice.org/archives/33969?



Professor Brook K. Baker
Health GAP (Global Access Project) &
Northeastern U. School of Law, Program on Human Rights and the Global Economy
Honorary Research Fellow, Faculty of Law, Univ. of KwaZulu Natal, SA
400 Huntington Ave.
Boston, MA 02115 USA
(w) 617-373-3217
(c) 617-259-0760
(f) 617-373-5056
b.baker at neu.edu



More information about the Ip-health mailing list